SynInnova is a reputed Canadian contract research organization (CRO) established over a decade ago in the state-of-the art facilities of NINT building in the University of Alberta Campus. Easy access to the scientific journals, and analytical tools and employing the high calibre scientists from the University campus helped us in building the team and providing speedy service to our clients.
What we do:
We support scientific research worldwide by preparing and supplying robust and unique research chemicals to fulfill of your research needs. Furthermore, we support your life science research in major therapeutic areas like oncology, virology, anti-infective, diabetes, autoimmune diseases, inflammation and pain, Alzheimer and so on by supplying early, mid-stage and advanced key chemical intermediates. These biological targets are of diverse in nature like Inhibitors, Agonists, Antagonists, Modulators and Blockers. Furthermore, we could synthesize FDA approved drugs and drugs under clinical trials as reference compounds. We could also assist you in making large number of analogs based on your proprietary designed scaffold in a specific therapeutic area.
Since 2008 we have collaborated with multinational companies like Pfizer, Merck, Gilead, Sanofi-Aventis, Bayer, Novartis, Abbott, Sigma-Aldrich, Alfa-Aesar and worked with over 300 research labs in 20 different countries. Institutes like NIH, NRC, Stanford University and UCLA are to name a few. We have supported in various ways including synthesizing isotopic labelled compounds, drug impurities and metabolites and many complex organic molecules that are not commercially available. Completing projects on time at competitive price and scalable to gram quantity is our strength.
